Cytokine circuits in tuberculosis

Infectious Agents and Disease

Volumn 5, Issue 2, 1996, Pages 98-107

  Toossi, Zahra ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 6; MESSENGER RNA; PENTOXIFYLLINE; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 12; RECOMBINANT INTERLEUKIN 2; THALIDOMIDE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; BACTERIAL VIRULENCE; DELAYED HYPERSENSITIVITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOREGULATION; MACROPHAGE ACTIVATION; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; T LYMPHOCYTE ACTIVATION; TUBERCULOSIS; TUBERCULOUS PLEURISY; VIRUS REPLICATION;

ANTIGENS, BACTERIAL; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; INTERFERON TYPE II; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MONOCYTES; TH1 CELLS; TH2 CELLS; TRANSFORMING GROWTH FACTOR BETA; TUBERCULOSIS, PULMONARY;

EID: 0029874380     PISSN: 10562044     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (94)

1. Abou-Zeid C, Ratliff TL, Wiker HG, Harboe M, Bennedsen J, Rook GAW. Characterization of fibronectin-binding antigens released by Mycobacterium tuberculosis and Mycobacterium bovis BCG. Infect Immun 1988;56:3046-7.
2. Ahuja SS, Paliogianni F, Yamada H, Balow JE, Boumpas DT. Effect of transforming growth factor-β on early and late activation events in human T cells. J Immunol 1993;150: 3109-18.
3. Andrade-Arzabe R, Machado IV, Fernandez B, Blanca I, Ramirez R, Bianco NE. Cellular immunity in current active pulmonary tuberculosis. Am Rev Respir Dis 1991;143:496-500.
4. Anscher MS, Peters WP, Reisenbichler H, Petros WP, Jirtle RL. Transforming growth factor β as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N Engl J Med 1993;328:1592-7.
5. Averill L, Toossi Z, Aung H, Boom H, Ellner JJ. Regulation of tumor necrosis factor-α production in monocytes in response to the 30kDa antigen of Mycobacterium tuberculosis. Infect Immun 1995;63:3206-8.
6. Barnes PF, Fong F-J, Brennan PJ, Twomey PE, Mazmuder A, Modlin RL. Local production of TNFα and IFNγ in tuberculous pleuritis. J Immunol 1990;45:149-54.
7. Barnes PF, Lu S, Abrams JS, Wang E, Yamamura M, Modlin RL. Cytokine production at the site of disease in human tuberculosis. Infect Immun 1993;61:3482-9.
8. Barnes PF, Mistry SD, Cooper CL, Pirmez C, Rea TH, Modlin RL. Compartmentalization of a CD4+ T lymphocyte subpopulation in tuberculous pleuritis. J Immunol 1989;142:1114-9.
9. Bermudez LEM, Young LS. Tumor necrosis factor, alone or combined with IL-2, but not IFNγ is associated with macrophage killing of Mycobacterium avium complex. 1988;140: 3006-13.
10. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 1991;174:1549-55.
11. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med 1994;331:1286-90.
12. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E. Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 1992;360:361-4.
13. Border WA, Rusolahti ER. Transforming growth factor β in disease: the dark side of tissue repair. J Clin Invest 1992;90:1-7.
14. Brabletz T, Pfeuffer I, Schorr E, Siebelt F, Wirth T, Serfling E. Transforming growth factor β and cyclosporin A inhibit the inducible activity of the interleukin-2 gene in T cells through a non canonical octamer-binding site. Mol Cell Biol 1993;13:1155-62.
15. Broekelmann TJ, Limper AH, Colby TV, McDonald JA. Transforming growth factor β is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci USA 1991;88:6642-8.
16. Chan J, Xing Y, Magliozzo RS, Bloom BR. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediaries produced by activated murine macrophages. J Exp Med 1992;175:111-22.
17. Chantry D, Turner M, Abney E, Feldmann M. Modulation of cytokine production by transforming growth factor-beta. J Immunol 1989;142:4295-300.
18. Cooper MA, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in Interferonγ gene-disrupted mice. 1993;178:2243-7.
19. Dahl KE, Shiratsuchi H, Hamilton BD, Ellner JJ, Toossi Z. Selective induction of TGF-β in human monocytes by lipoarabinomannan of M. tuberculosis, (in press) Infect Immun 1995.
20. D'Andrea A, Ma X, Aste-Amezaga M, Paganin C, Trinchieri G. Stimulatory and inhibitory effects of interleukin IL-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells. J Exp Med 1995;181:537-46.
21. Denis M. Killing of Mycobacterium tuberculosis within human monocytes: activation by cytokines and calcitriol. Clin Exp Immunol 1991;84:200-8.
22. Ding A, Nathan C, Srimal S. Macrophage deactivating factor and TGFβ inhibit of macrophage nitrogen oxide synthesis by IFNγ. J Immunol 1990;145:940-5.
23. Ellner JJ. Suppressor adherent cells in human tuberculosis. J Immunol 1978;121:2573-8.
24. Ellner JJ, Boom WB, Edmonds KL, Rich EA, Toossi Z, Wallis RS. Regulation of the immune response to Mycobacterium tuberculosis. In: Microbial determinants of virulence and host response. Washington DC: American Society for Microbiology, 1990:77-91.
25. Ellner JJ, Spagnuolo PJ, Schacter BZ. Augmentation of selective monocyte function in tuberculosis. J Infect Dis 1981; 144:391-8.
26. Enelow RI, Sullivan GW, Carper HT, Mandell G. Induction of MGC formation from in vitro culture of human monocytes with IL-3 and IFNγ. Comparison with other simulating factors. Am J Respir Cell Mol Biol 1992;6:57-62.
27. Espevik T, Figari IS, Shalaby MR, Lackides GA, Lewis GD. Shepard HM, Palladino MA Jr. Inhibition of cytokine pro-duction by cyclosporin A and transforming growth factor β. J Exp Med 1987;166:571-6.
28. Flesch IE, Kaufman SHE. Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates. Infect Immun 1991;59:3213-8.
29. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon γ in resistance to Mycobacterium tuberculosis. J Exp Med 1993;178:2249-54.
30. Fontana A, Frei K, Bodmer S, Hoefer E, Scheier MH, Palladino MA, Zinkernagel M. Transforming growth factor-β inhibits the generation of cytotoxic T cells in virus-infected mice. J Immunol 1989;143:3220-34.
31. Fujiwara H, Kleinhenz ME, Wallis RS, Ellner JJ. Increased interleukin-1 production and monocyte suppressor cell activity associated with human tuberculosis. Am Rev Respir Dis 1986;133:73-7.
32. Fujiwara H, Tsuyuguchi I. Frequency of tuberculin-reactive T-lymphocytes in pleural fluid and blood from patients with tuberculous pleuritis. Chest 1984;89:530-5.
33. Fulton SA, Johnsen JM, Boom WH. IL-12 production by human monocytes after infection with Mycobacterium tuberculosis: the role of phagocytosis, (submitted) 1995.
34. Gazzinelli RT, Hieny S, Wynn TA, Wolf S, Sher A. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon γ by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc Natl Acad Sci USA 1993;90:6115-9.
35. Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK. Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med 1993;77:1505-9.
36. Hirsch CS, Ellner JJ, Russell DG, Rich EA. Complement receptor mediated uptake and tumor necrosis α-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. J Immunol 1994;152:743-9.
37. Hirsch CS, Hussain R, Toossi Z, Dawood G, Shahid F, Ellner JJ. Cross modulation by transforming growth factor β in human tuberculosis; suppression of antigen-driven blastogenesis and interferon γ production, (submitted) 1995.
38. Hirsch CS, Toossi Z, Hussain R, Ellner JJ. Suppression of T-cell responses by TGF-β in tuberculosis. J Invest Med 1995;43:365A.
39. Hirsch CS, Yoneda T, Ellner JJ, Averill LE, Toossi Z. Enhancement of intracellular growth of M. tuberculosis in human monocytes by transforming growth factor beta. J Infect Dis 1994;170:1229-37.
40. Holland SM, Einstein MD, Kuhns DB, Turner ML, Fleisher TA, Strober W, Gallin JI. Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon γ. N Engl J Med 1994;330:1348-54.
41. Hussain R, Dawood G, Obaid M, Toossi Z, Wallis RS, Minai A, Dojki M, Sturm AW, Ellner JJ. Depressed cellular and augmented humoral responses in patients with active tuberculosis from Pakistan, (submitted) 1995.
42. Huygen K, van Vooren JP, Turneer M, Bosmans R, Dierckx P, De Bruyn J. Specific lymphoproliferation, gamma interferon production, and serum immunoglobulin G directed against a purified 32 kDA mycobacterial protein antigen (P32) in patients with active tuberculosis. Scand J Immunol 1988;27:187-94.
43. Jones BE, Young MM, Antoniskis D, Davidson PT, Kramer F, Barnes PF. Relationship of the manifestation of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis 1993;48:1292-7.
44. Khalil N, Whitman C, Zuo L, Danielpour D, Greenberg A. Regulation of alveolar macrophage transforming growth factor β secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat. J Clin Invest 1993;92: 1812-7.
45. Kim SJ, Angel P, Lafyatis R, Hattori K, Kim KY, Sporn MB, Karin M, Roberts AB. Autoinduction of transforming growth factor β1 is mediated by the AP-1 complex. Mol Cell Biol 1990;10:1492-6.
46. Kindler V, Syepino AP, Gran GE, et al. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 1989;56:731-40.
47. Kleinhenz ME, Ellner JJ. Immunoregulatory adherent cells in human tuberculosis: radiation-sensitive antigen-specific suppression by monocytes. J Infect Dis 1985;152:171-6.
48. Kleinhenz ME, Ellner JJ. Antigen responsiveness during tuberculosis: regulatory interaction of T-cell subpopulations and adherent cells. J Lab Clin Med 1987;10:31-40.
49. 2 production and antileishmanial capacity of human cultured monocytes mediated by IFN gamma. J Immunol 1989;143:3020-4.
50. Limper AH, Colby TV, Asakura S, DeRmee RA. Immunohistochemical granulomas of pulmonary sarcoidosis. Am J Respir Crit Care Med 1994;149:197-202.
51. Lorgat F, Keraan MM, Lukey PT, Ress SR. Evidence for in vivo generation of cytotoxic T cells: PPD-stimulated lymphocytes from tuberculous pleural effusions demonstrate enhanced cytotoxicity with accelerated kinetics of induction. Am Rev Respir Dis 1992;145:418-23.
52. McCartney-Francis NL, Wahl SM. Transforming growth factor β: a matter of life and death. J Leukoc Biol 1994;55: 401-9.
53. Muller IS, Cobbold SP, Waldman H, Kaufman SHE. Impaired resistance to Mycobacterium tuberculosis infection after selective in vivo depletion of L3T4+ and Lyt-2+ T cells. Infect Immun 1988;55:2037-41.
54. Nathan CF, Kaplan G, Levis WR, Nusrat A, Witmer MD, Sherwin SA, Job CK, Path FRC, Horowitz CR, Steinman RM, Cohn ZA. Local and systemic effects of intradermal recombinant interferon-γ in patients with lepromatous leprosy. N Engl J Med 1986;315:6-9.
55. Ogawa T, Uchida H, Kusumoto Y, Mori Y, Yamamura Y, Hamada S. Increase in tumor necrosis factor alpha and interleukin-6 secreting cells in peripheral blood mononuclear cells from subjects infected with Mycobacterium tuberculosis. Infect Immun 1991;59:3021-5.
56. Onwubalili JK, Scott GM, Robinson JA. Deficient immune interferon production in tuberculosis. Clin Exp Immunol 1985;59:405-13.
57. Orme IM, Collins FM. Protection against Mycobacterium tuberculosis infection by adoptive immunotherapy. J Exp Med 1983;58:74-83.
58. Orme IM, Miller ES, Roberts AD. T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection. J Immunol 1992;148:189-96.
59. Pal PG, Horowitz MA. Immunization with extracellular proteins of M. tuberculosis induces cell-mediated immune responses with substantial protective immunity in a guinea pig model of pulmonary tuberculosis. Infect Immun 1992;60: 4782-92.
60. Pedrazzini TK, Hug K, Louis JA. Importance of L3T4+ and Ly-2+ cells in the immunologic control of infection with Mycobacterium bovis strain Bacillus Calmette Guerin in mice. J Immunol 1987;139:2032-7.
61. Piguet PF. Cytokines involved in pulmonary fibrosis. Int Rev Exp Pathol 1993;34B:173-81.
62. Rich EA, Kunuth CK, Hamilton BD, Toossi Z. Mycobacterium tuberculosis stimulated production of nitric oxide and inducible nitric oxide synthase mRNA by human alveolar macrophages. J Invest Med 1995;43:209A.
63. Rich EA, Panuska JR, Wallis RS, Wolf CB. Leonard ML, Ellner JJ. Dyscoordinate expression of tumor necrosis α fac-tor by human alveolar macrophages. Am Rev Respir Dis 1989;139:1010-5.
64. Rook GAW, Taverne J, Leveton C, Steele J. The role of gamma Interferon, vitamin D3 metabolites, and tumor necrosis factor in the pathogenesis of tuberculosis. Immunology 1987;67:229-34.
65. Schmitt E, Meuret G, Stix L. Monocyte recruitment in tuberculosis and sarcoidosis. Br J Haematol 1977;35:11-7.
66. Selwyn P, Hartel D, Lewis VA, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989;320:545-50.
67. Shiratsuchi H, Okuda Y, Tsuyuguchi I. Recombinant human IL-2 reverses in vitro deficient cell-mediated immune respones to tuberculin purified protein derivative by lymphocytes of tuberculous patients. Infect Immun 1987;55:2126-31.
68. Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NK-κB. Annu Rev Cell Biol 1994;10:405-55.
69. Sieling PA, Abrams JS, Yamamura M, Salgame P, Bloom BR, Rea TH, Modlin RL. Immunosuppressive roles for IL-10 and IL-4 in human infection. J Immunol 1993;150:5501-10.
70. Squires KE, Brown ST, Armstrong WE, Murphy WF, Murray HW. Interferon γ treatment for Mycobacterium aviumintracellular complex bacillemia in patients with AIDS. J Infect Dis 1992;166:686-92.
71. Street NE, Mossman TR. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J 1991;5:171-5.
72. Sucrel HM, Tory-Blomberg M, Paulie S, Anderson G, Moreno C, Pasvol G, Ivanyi J. Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology 1994;81:171-6.
73. Takashima T, Ueta C, Tsuyuguchi I, Kishimoto S. Production of tumor necrosis factor by monocytes from patients with pulmonary tuberculosis. Infect Immun 1990;58:3286-92.
74. Toossi Z, Edmonds KE, Tomford WJ, Ellner JJ. Suppression of PPD-induced interleukin-2 production by interaction of CD 16 lymphocytes and adherent mononuclear cells in tuberculosis. J Infect Dis 1989;159:352-6.
75. Toossi Z, Gogate P, Shiratsuchi H, Young T, Ellner JJ. Enhanced production of transforming growth factor-β (TGF-β) by blood monocytes from patients with active tuberculosis and presence of TGF-β in tuberculous granulomatous lung lesions. J Immunol 1995;54:465-73.
76. Toossi Z, Hirsch CS, Hamilton BD, Knuth CK, Friedlander MA, Rich EA. Decreased production of transforming growth factor β1 (TGF-β1) in human alveolar macrophages. (in press) J Immunol 1995.
77. Toossi Z, Kleinhenz ME, Ellner JJ. Defective interleukin-2 production and responsiveness in human pulmonary tuberculosis. J Exp Med 1986;163:1162-72.
78. Toossi Z, Lapurga JP, Ondash R, Sedor JR, Ellner JJ. Expression of functional interleukin 2 receptors by peripheral blood monocytes from patients with active pulmonary tuberculosis. J Clin Invest 1990;85:1777-84.
79. Toossi Z, Young TG, Averill LE, Hamilton BD, Shiratsuchi H, Ellner JJ. Induction of transforming growth factor-β (TGF-β) by purified protein derivative (PPD) of Mycobacterium tuberculosis. Infect Immun 1995;63:224-8.
80. Torres M, Mendez-Sampiero P, Jimenez-Zamudio L, Teran L, Camerena A, Quezada R, Ramos E, Sada E. Comparison of the immune response against Mycobacterium tuberculosis antigens between a group of patients with active pulmonary tuberculosis and healthy household contacts. Clin Exp Immunol 1995;96:75-8.
81. Tramontana JM, Molloy A, Makonkawkeyoon S, Burroughs M, Akarasewi P, Kapla G. The effect of thalidomide on the clinical and immunological status of tuberculosis patients. In: U.S. Japan Cooperative Medical Science Program. Twenty-eighth joint conference on tuberculosis and leprosy. Washington, DC 1993:234-7.
82. Tsunawki S, Sporn M, Nathan C. Deactivation of macrophages by TGF-β. Nature 1988;334:260-3.
83. Tweardy DJ, Schacter BZ, Ellner JJ. Association of altered dynamics of monocyte surface expression of human leukocyte antigen-DR with immunosuppression in tuberculosis. J Infect Dis 1984;149:31-7.
84. Valone SE, Rich EA, Wallis RS, Ellner J. Expression of tumor necrosis factor α in vitro by human mononuclear phagocytes stimulated with whole Mycobacterium bovis BCG and mycobacterial antigens. Infect Immun 1988;56: 3313-5.
85. Vanham G, Edmonds KE, Qing L, Hom D, Toossi Z, Joness B, Daley C, Huebner R, Kestens L, Gigase P, Ellner JJ. Generalized immune activation in pulmonary tuberculosis: co-activation with HIV infection. Clin Exp Immunol 1996 (in press).
86. Vilcek J, Klion A, Henriksen-DeStefano D, Zemtsov A, Davidson DM, Davidson M, Friedman-Kien A. Defective gamma-interferon production in peripheral blood leukocytes of patients with acute tuberculosis. J Clin Immunol 1986;6: 146-51.
87. Wahl SM. Transforming growth factor beta: a cause and a cure. J Clin Immunol 1992;2:61-71.
88. Wallis RS, Fujiwara H, Ellner JJ. Direct stimulation of monocyte release of interleukin 1 by mycobacterial protein antigens. J Immunol 1986;36:193-6.
89. Wallis RS, Paranjape R, Phillips M. Identification by two-dimensional gel electrophoresis of a 58-kilodalton tumor necrosis factor-inducing protein of Mycobacterium tuberculosis. Infect Immun 1993;61:627-32.
90. Wu CY, Demeure C, Kiniwa M, Gately M, Delepess G. IL-12 induces the production of IFN-γ by neonatal human CD4 T cells. J Immunol 1993;151:1938-49.
91. Yamamura M, Uyemura K, Deans RJ, Weinberg K, Rea TH, Bloom BR, Modlin RL. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1991;254:277-9.
92. Zhang M, Gately MK, Modlin RL, Barnes PF. Interleukin 12 at the site of disease in tuberculosis. J Clin Invest 1994;93: 1733-9.
93. Zhang M, Gong J, Iyer D, Jones BE, Modlin RL, Barnes PF. T-cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection. J Clin Invest 1994; 94:2435-40.
94. Zugmaier G, Paik S, Wilding G, et al. Transforming growth factor β1 induces cachexia and systemic fibrosis without an antitumor effect in nude mice. Cancer Res 1991;51:3590-4.